In this study, there was no correlation between PD-L1 expression and clinicopathological factors such as tumor size, pTNM classification, or late-stage, which are known to be prognostic, and risk factors for recurrence of thyroid cancer as reported by Ahn S, et al. [25]. This evidence concerns the gene CD274 and thyroid cancer.